Ventilatory support versus ECMO for severe adult respiratory failure

The Lancet

Volumn 375, Issue 9714, 2010, Pages 549-

  Jainandunsing, Jayant S ^a   Ismael, Farouq ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT RESPIRATORY DISTRESS SYNDROME; ALBUMIN DIALYSIS; ASSISTED VENTILATION; DEATH; DISABILITY; DISEASE SEVERITY; EXTRACORPOREAL OXYGENATION; HUMAN; INTERMETHOD COMPARISON; LETTER; LIVER DYSFUNCTION; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RESPIRATORY FAILURE; SAMPLE SIZE; SURVIVAL; THERAPY EFFECT; ARTIFICIAL VENTILATION; METHODOLOGY; NOTE; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

DATA INTERPRETATION, STATISTICAL; EXTRACORPOREAL MEMBRANE OXYGENATION; HUMANS; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY INSUFFICIENCY; SURVIVAL; TREATMENT OUTCOME;

EID: 76249090214     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)60221-8     Document Type: Letter

References (1)

1. Peek G.J., Mugford M., Tiruvoipati R., et al., for the CESAR trial collaboration. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 374 (2009) 1351-1363